Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Great Lakes Chemical Corporation was a major global producer of specialty chemicals, including flame retardants, polymer additives, and performance chemicals. In the life sciences sector, the company was a significant provider of fine chemicals and pharmaceutical intermediates, leveraging its expertise in bromine chemistry and complex organic synthesis. The company operated a dedicated Fine Chemicals business that served as a contract manufacturer for the pharmaceutical and agrochemical industries. In 2005, Great Lakes Chemical merged with Crompton Corporation to form Chemtura Corporation, which was later acquired by the German specialty chemicals company LANXESS in 2017.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Great Lakes Chemical.